Jilin Jian Yisheng Pharmaceutical Co Ltd Market Cap ($291.06 Million)
Market Cap & Net Worth: Jilin Jian Yisheng Pharmaceutical Co Ltd (002566)
Jilin Jian Yisheng Pharmaceutical Co Ltd market cap. Jilin Jian Yisheng Pharmaceutical Co Ltd (SHE:002566) has a market capitalization of $291.06 Million (CN¥1.99 Billion) as of November 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #14667 globally and #4317 in its home market, demonstrating a -8.24% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jilin Jian Yisheng Pharmaceutical Co Ltd's stock price CN¥6.01 by its total outstanding shares 330951600 (330.95 Million). Also see cash flow conversion of Jilin Jian Yisheng Pharmaceutical Co Ltd for how efficiently the company converts equity into cash flow.
Jilin Jian Yisheng Pharmaceutical Co Ltd Market Cap History (2015–2026)
Jilin Jian Yisheng Pharmaceutical Co Ltd market cap history from 2015 to 2026. Data shows change from $751.81 Million to $291.06 Million (-7.66% CAGR). Check latest Jilin Jian Yisheng Pharmaceutical Co Ltd stock price today for real-time trading data and today's change.
Jilin Jian Yisheng Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jilin Jian Yisheng Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Jilin Jian Yisheng Pharmaceutical Co Ltd growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.58x
Jilin Jian Yisheng Pharmaceutical Co Ltd's market cap is 0.58 times its annual revenue
Latest Price to Earnings (P/E) Ratio
12.74x
Jilin Jian Yisheng Pharmaceutical Co Ltd's market cap is 12.74 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $590.38 Million | $939.01 Million | $13.19 Million | 0.63x | 44.74x |
| 2017 | $403.12 Million | $1.03 Billion | $60.07 Million | 0.39x | 6.71x |
| 2018 | $266.67 Million | $975.09 Million | $69.08 Million | 0.27x | 3.86x |
| 2019 | $309.88 Million | $1.01 Billion | $76.60 Million | 0.31x | 4.05x |
| 2020 | $311.64 Million | $842.59 Million | $80.06 Million | 0.37x | 3.89x |
| 2021 | $424.44 Million | $877.93 Million | $96.02 Million | 0.48x | 4.42x |
| 2022 | $381.78 Million | $830.04 Million | $83.10 Million | 0.46x | 4.59x |
| 2023 | $422.50 Million | $853.66 Million | $94.73 Million | 0.49x | 4.46x |
| 2024 | $330.28 Million | $668.47 Million | $52.09 Million | 0.49x | 6.34x |
| 2025 | $369.51 Million | $640.17 Million | $29.00 Million | 0.58x | 12.74x |
Competitor Companies of 002566 by Market Capitalization
Companies near Jilin Jian Yisheng Pharmaceutical Co Ltd in the global market cap rankings as of November 4, 2026. Also see Jilin Jian Yisheng Pharmaceutical Co Ltd balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Jilin Jian Yisheng Pharmaceutical Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Jilin Jian Yisheng Pharmaceutical Co Ltd (2015–2026)
Market capitalization of Jilin Jian Yisheng Pharmaceutical Co Ltd from 2015 to today. Between 2015 and today, Jilin Jian Yisheng Pharmaceutical Co Ltd's market cap moved from $751.81 Million to $ 291.06 Million, with a yearly change of -7.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥291.06 Million | -21.23% |
| 2025 | CN¥369.51 Million | +11.88% |
| 2024 | CN¥330.28 Million | -21.83% |
| 2023 | CN¥422.50 Million | +10.66% |
| 2022 | CN¥381.78 Million | -10.05% |
| 2021 | CN¥424.44 Million | +36.20% |
| 2020 | CN¥311.64 Million | +0.57% |
| 2019 | CN¥309.88 Million | +16.20% |
| 2018 | CN¥266.67 Million | -33.85% |
| 2017 | CN¥403.12 Million | -31.72% |
| 2016 | CN¥590.38 Million | -21.47% |
| 2015 | CN¥751.81 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Jilin Jian Yisheng Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $291.06 Million USD |
| MoneyControl | $291.06 Million USD |
| MarketWatch | $291.06 Million USD |
| marketcap.company | $291.06 Million USD |
| Reuters | $291.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jilin Jian Yisheng Pharmaceutical Co Ltd
Jilin Jian Yisheng Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, wholesale, retail, import, and export of pharmaceutical products in China. The company offers paper packaging products; drugs comprising capsules, injections, tablets, granules, and other drug products; cosmetics; ginseng products; bee products; and food products comprisi… Read more